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On January 14–15, 2003, more
than 60 scientists, public health offi-
cials, and clinicians from throughout
the southeastern United States gath-
ered in Atlanta to present data from
the 2001 and 2002 West Nile virus
(WNV) epidemics. The aim of the
daylong conference, hosted by the
Southeastern Center for Emerging
Biological Threats at Emory
University, was to assemble a diverse
perspective on WNV by sharing
knowledge, identifying key questions
for research about the disease and pre-
vention, and fostering collaborations
between epidemiologists, veterinari-
ans, laboratorians, and clinicians.
In the overview presentation, the
experiences of state health officials,
clinical spectrum and pathogenesis,
laboratory diagnostics, veterinary
issues, surveillance, and vector control
were discussed. The 2002 epidemic
produced the largest annual number of
cases to date, and four novel modes of
transmission were discovered: 1)
transplanted organs or tissue, includ-
ing blood; 2) breast milk from an
infected mother; 3) percutaneous
exposure to infected tissue or serum
among laboratory and hospital work-
ers; and 4) transplacental exposure to
fetuses in utero, resulting in birth
defects. In addition, WNV-associated
acute flaccid paralysis was discussed;
the paralysis is caused by localized
infection of the anterior horn cells of
the spinal cord, resulting in signs and
symptoms similar to poliomyelitis. 
State epidemiologists or their rep-
resentatives presented information
about the state epidemics in the south-
eastern United States. The experi-
ences in four states (Florida, Georgia,
Louisiana, and Mississippi) were
common in their themes of expansion
of WNV epidemics,  concentrated
nature of outbreaks, importance of
protection from mosquito bites, limi-
tations of diagnostic methods, and
dynamics of WNV spread in the
United States from 2001 to 2002.
Significant differences also emerged
regarding the observed benefits of
mosquito control activities and the
value of animal surveillance as an
early detection system. Also, while
the states unanimously agreed that
collaboration among local, state, and
federal public health agencies, aca-
demic research institutions, and other
nongovernmental organizations is
critical to responding effectively to
WNV, the degree to which such col-
laborations actually occurred and the
existence of previously established
relationships varied.
Several clinicians discussed the
pathogenesis and clinical aspects of
the disease. The pathogenesis of
WNV was reviewed; clinicians sug-
gested that infections of the central
nervous system can demonstrate any
or all of three distinct characteristics:
neuroinvasiveness (the ability to enter
the nervous system), neurotropism
(the ability to infect neural cells), and
neurovirulence (the ability to cause
neurologic disease). WNV possesses
all three. The virus can enter the nerv-
ous system, as shown by the
encephalitis that occurs in approxi-
mately 1 in 150 infected persons; it
has been shown to infect neurons;
approximately 10% of patients in
which the virus has invaded the nerv-
ous system eventually die. One pre-
senter suggested that the virus had
changed in the last 60 years, evolving
into a more virulent strain. The neuro-
logic manifestations of the disease
were described, including weakness
and flaccid paralysis (which can occur
even without fever or meningoen-
cephalitis). 
WNV infection in patients with
HIV was also described. Two HIV-
infected patients, with CD4 cell
counts below 200 cells/µL were iden-
tified with WNV by the presence of
immunoglobulin M antibodies to
WNV. The first was a 50-year-old
homeless man co-infected with tuber-
culosis. Despite treatment including
intravenous acyclovir, the patient con-
tinued to deteriorate, and died 18 days
after admission. An autopsy revealed
meningitis. The second HIV-positive
patient diagnosed with WNV was a
48-year-old man who arrived at the
emergency room with fever,
headache, and confusion; he reported
feeling “slow,” and indeed was slow
to respond to questions. This patient
improved rapidly and was discharged
after 3 days. 
Information about intracellular
host-virus interactions was summa-
rized. Studies in mice have identified
a genetic allele that apparently con-
fers resistance to flaviviruses.
Although humans do not have a direct
genetic homologue, studies to identify
genetic differences to explain differ-
ent clinical outcomes should be pur-
sued. Results of a case-control study
suggested that the greatest increases
in risk were related to environmental
factors favoring mosquito popula-
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Conference Summary
West Nile Virus and
Wildlife Health
The West Nile Virus and Wildlife
Health Workshop, hosted by the
Smithsonian Institution, National
Audubon Society, U.S. Geological
Survey, and U.S. Department of
Agriculture, was held February 5–7,
2003, at the Smithsonian Environ-
mental Research Center in Edgewater,
Maryland. The event was attended by
more than 100 scientists, who heard
29 speakers and participated in strate-
gy discussions during the 2-day meet-
ing. The main focus of the conference
was the present and future impact of
West Nile virus on wildlife popula-
tions. Talks and discussions empha-
sized how basic research, public
health, and land management can con-
tribute to our understanding of the dis-
ease’s impact and spread. A primary
objective of this meeting was to devel-
op future research priorities from both
basic and applied perspectives. 
The conference centered around
four main themes: 1) host, vector, and
pathogen interactions (disease ecolo-
gy); 2) vertebrate behavior and ecolo-
gy; 3) vector behavior and ecology;
and 4) modeling and spatial statistics.
We describe some of the findings
from the meeting. For an in-depth
summary of this meeting, please visit
the conference website for meeting
abstracts and a downloadable confer-
ence white paper (available from:
URL: www.serc.si.edu/migratory-
birds/migratorybirds_index.htm).
West Nile virus (WNV) has spread
rapidly across North America since its
probable introduction to the New
York City area in 1999 (D.J. Gubler,
Centers for Disease Control and
Prevention, Fort Collins, CO). By
December 2002, the Canadian
provinces of Saskatchewan, Quebec,
Ontario, Nova Scotia, and Manitoba
reported dead birds that tested posi-
tive for WNV. By winter 2002, only
four states in the continental United
States remained free of confirmed
WNV infection; the virus was expect-
ed to reach the West Coast later in the
year. WNVhas also found its way into
tropical regions. One case in a person
was reported in 2001 from the
Cayman Islands. Additionally, resi-
dent birds from Jamaica (January
2002) and the Dominican Republic
tions. These findings in turn raised
questions about factors involved in
human susceptibility, risks of pesti-
cide exposure, efficacy of mosquito
control, the value of sentinel animals
in surveillance, and the roles played
by various species in virus transmis-
sion and amplification.
The ability to diagnose WNV in
the laboratory emphasized the role of
pathology, including histopathology,
electron microscopy, immunohisto-
chemistry, polymerase chain reaction,
and virus isolation. Few of these tests
are entirely sensitive or specific. The
challenges involved in the pathologic
diagnosis in animals because of the
large diversity of infected species
were discussed. The single most
urgent concern, repeatedly empha-
sized by state public health officials
and clinicians, is the need for a faster,
simpler diagnostic test for WNV that
would ease the amount of work by
public health laboratories, assist
physicians in correctly diagnosing
infected patients, and improve surveil-
lance by identifying subclinical cases.
The problems of vector control
and the best application of these meth-
ods were also emphasized. The cost of
these programs and proof of effective-
ness will require careful research,
including the identification of specific
mosquito vectors and assessment of
the long-term safety of pesticides and
personal repellant applications. The
most important principle in attempt-
ing emergency vector control is to
consider it early, before the epidemic
has evolved.
Data from in vitro studies evaluat-
ed the interaction of viral vectors and
amplification hosts. These studies
might elucidate the importance of
birds, horses, and household pets in
maintenance of epidemics. Because
wild birds play a key role in the
spread of WNV, the exact nature of
that role must be clarified to predict
the development and expansion of
future epidemics. 
The variation in changing epi-
demiology of the states’ experiences
to date with WNV, even within the
southeastern United States, clearly
demonstrates that research needs to be
replicated in numerous localities;
what succeeds in one state may not
prove successful in another. Whether
epidemics will continue to expand in
size and geographic distribution or
whether a more sporadic pattern of
occurrence will emerge is still
unclear. Controlling WNV in the
southeastern United States will take a
concerted, cohesive effort. The con-
tinued collaboration of the diverse
scientists in this meeting will aid in
this effort. Presentations from this
conference are available on the Web
site for Southeastern Center for
Emerging Biological Threats (avail-
able from: URL: www.secenterbio-
threats.org).
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